Castle Biosciences, Inc. (CSTL)
33.79
-0.71
(-2.06%)
USD |
NASDAQ |
Nov 13, 16:00
33.77
-0.02
(-0.06%)
After-Hours: 19:59
Castle Biosciences Net Income (Quarterly) : -4.10M for Sept. 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -4.10M |
| June 30, 2026 | -2.06M |
| March 31, 2026 | -14.52M |
| December 31, 2025 | -2.332M |
| September 30, 2025 | -0.501M |
| June 30, 2025 | 4.523M |
| March 31, 2025 | -25.85M |
| December 31, 2024 | 9.59M |
| September 30, 2024 | 2.269M |
| June 30, 2024 | 8.92M |
| March 31, 2024 | -2.534M |
| December 31, 2023 | -2.58M |
| September 30, 2023 | -6.905M |
| June 30, 2023 | -18.78M |
| March 31, 2023 | -29.20M |
| December 31, 2022 | -20.62M |
| September 30, 2022 | -20.25M |
| Date | Value |
|---|---|
| June 30, 2022 | -1.648M |
| March 31, 2022 | -24.62M |
| December 31, 2021 | -6.43M |
| September 30, 2021 | -11.79M |
| June 30, 2021 | -8.791M |
| March 31, 2021 | -4.28M |
| December 31, 2020 | -4.889M |
| September 30, 2020 | -4.589M |
| June 30, 2020 | -1.376M |
| March 31, 2020 | 0.57M |
| December 31, 2019 | 2.055M |
| September 30, 2019 | 5.849M |
| June 30, 2019 | -1.269M |
| March 31, 2019 | -1.358M |
| September 30, 2018 | -3.45M |
| June 30, 2018 | -3.155M |
| March 31, 2018 | -3.630M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| RadNet, Inc. | 19.15M |
| Lumexa Imaging Holdings, Inc. | 7.178M |
| Quest Diagnostics, Inc. | 324.00M |
| Labcorp Holdings, Inc. | 263.10M |
| OPKO Health, Inc. | -35.56M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 102.89M |
| Total Expenses (Quarterly) | 106.99M |
| EPS Diluted (Quarterly) | -0.1338 |
| Enterprise Value | 798.68M |
| Gross Profit Margin (Quarterly) | 74.00% |
| Profit Margin (Quarterly) | -3.98% |
| Earnings Yield | -2.27% |
| Normalized Earnings Yield | -1.970 |